Anti-bipolar therapy: Mechanism of action of lithium

Research output: Contribution to journalArticle

338 Citations (Scopus)

Abstract

This review introduces the concepts that multiple actions of lithium are critical for its therapeutic effect, and that these complex effects stabilize neuronal activities, support neural plasticity, and provide neuroprotection. Three interacting systems appear most critical, (i) Modulation of neurotransmitters by lithium likely readjusts balances between excitatory and inhibitory activities, acid decreased glutamatergic activity may contribute to neuroprotection. (ii) Lithium modulates signals impacting on the cytoskeleton, a dynamic system contributing to neural plasticity, at multiple levels, including glycogen synthase kinase-3β, cyclic AMP-dependent kinase, and protein kinase C, which may be critical for the neural plasticity involved in mood recovery and stabilization. (iii) Lithium adjusts signaling activities regulating second messengers, transcription factors, and gene expression. The outcome of these effects appears likely to result in limiting the magnitudes of fluctuations in activities, contributing to a stabilizing influence induced by lithium, and neuroprotective effects may be derived from its modulation of gene expression.

Original languageEnglish
Pages (from-to)117-128
Number of pages12
JournalMolecular Psychiatry
Volume4
Issue number2
StatePublished - Apr 19 1999
Externally publishedYes

Fingerprint

Lithium
Neuronal Plasticity
Glycogen Synthase Kinase 3
Therapeutics
Gene Expression
Adenylate Kinase
Second Messenger Systems
Neuroprotective Agents
Therapeutic Uses
Cytoskeleton
Cyclic AMP
Protein Kinase C
Neurotransmitter Agents
Transcription Factors
Acids
Neuroprotection

Keywords

  • AP-1
  • Bipolar disorder
  • Cyclic AMP
  • Glutamate
  • Inositol
  • Lithium

ASJC Scopus subject areas

  • Molecular Biology
  • Psychiatry and Mental health

Cite this

Anti-bipolar therapy : Mechanism of action of lithium. / Jope, Richard S.

In: Molecular Psychiatry, Vol. 4, No. 2, 19.04.1999, p. 117-128.

Research output: Contribution to journalArticle

@article{8f442c03dfc045dc98882db908c70c12,
title = "Anti-bipolar therapy: Mechanism of action of lithium",
abstract = "This review introduces the concepts that multiple actions of lithium are critical for its therapeutic effect, and that these complex effects stabilize neuronal activities, support neural plasticity, and provide neuroprotection. Three interacting systems appear most critical, (i) Modulation of neurotransmitters by lithium likely readjusts balances between excitatory and inhibitory activities, acid decreased glutamatergic activity may contribute to neuroprotection. (ii) Lithium modulates signals impacting on the cytoskeleton, a dynamic system contributing to neural plasticity, at multiple levels, including glycogen synthase kinase-3β, cyclic AMP-dependent kinase, and protein kinase C, which may be critical for the neural plasticity involved in mood recovery and stabilization. (iii) Lithium adjusts signaling activities regulating second messengers, transcription factors, and gene expression. The outcome of these effects appears likely to result in limiting the magnitudes of fluctuations in activities, contributing to a stabilizing influence induced by lithium, and neuroprotective effects may be derived from its modulation of gene expression.",
keywords = "AP-1, Bipolar disorder, Cyclic AMP, Glutamate, Inositol, Lithium",
author = "Jope, {Richard S}",
year = "1999",
month = "4",
day = "19",
language = "English",
volume = "4",
pages = "117--128",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Anti-bipolar therapy

T2 - Mechanism of action of lithium

AU - Jope, Richard S

PY - 1999/4/19

Y1 - 1999/4/19

N2 - This review introduces the concepts that multiple actions of lithium are critical for its therapeutic effect, and that these complex effects stabilize neuronal activities, support neural plasticity, and provide neuroprotection. Three interacting systems appear most critical, (i) Modulation of neurotransmitters by lithium likely readjusts balances between excitatory and inhibitory activities, acid decreased glutamatergic activity may contribute to neuroprotection. (ii) Lithium modulates signals impacting on the cytoskeleton, a dynamic system contributing to neural plasticity, at multiple levels, including glycogen synthase kinase-3β, cyclic AMP-dependent kinase, and protein kinase C, which may be critical for the neural plasticity involved in mood recovery and stabilization. (iii) Lithium adjusts signaling activities regulating second messengers, transcription factors, and gene expression. The outcome of these effects appears likely to result in limiting the magnitudes of fluctuations in activities, contributing to a stabilizing influence induced by lithium, and neuroprotective effects may be derived from its modulation of gene expression.

AB - This review introduces the concepts that multiple actions of lithium are critical for its therapeutic effect, and that these complex effects stabilize neuronal activities, support neural plasticity, and provide neuroprotection. Three interacting systems appear most critical, (i) Modulation of neurotransmitters by lithium likely readjusts balances between excitatory and inhibitory activities, acid decreased glutamatergic activity may contribute to neuroprotection. (ii) Lithium modulates signals impacting on the cytoskeleton, a dynamic system contributing to neural plasticity, at multiple levels, including glycogen synthase kinase-3β, cyclic AMP-dependent kinase, and protein kinase C, which may be critical for the neural plasticity involved in mood recovery and stabilization. (iii) Lithium adjusts signaling activities regulating second messengers, transcription factors, and gene expression. The outcome of these effects appears likely to result in limiting the magnitudes of fluctuations in activities, contributing to a stabilizing influence induced by lithium, and neuroprotective effects may be derived from its modulation of gene expression.

KW - AP-1

KW - Bipolar disorder

KW - Cyclic AMP

KW - Glutamate

KW - Inositol

KW - Lithium

UR - http://www.scopus.com/inward/record.url?scp=0032947795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032947795&partnerID=8YFLogxK

M3 - Article

C2 - 10208444

AN - SCOPUS:0032947795

VL - 4

SP - 117

EP - 128

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 2

ER -